These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 29544192)

  • 21. 'Timed up and go' and brain atrophy: a preliminary MRI study to assess functional mobility performance in multiple sclerosis.
    Lorefice L; Coghe G; Fenu G; Porta M; Pilloni G; Frau J; Corona F; Sechi V; Barracciu MA; Marrosu MG; Pau M; Cocco E
    J Neurol; 2017 Nov; 264(11):2201-2204. PubMed ID: 28894919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term outcome of paediatric-onset multiple sclerosis: a population-based study.
    Harding KE; Liang K; Cossburn MD; Ingram G; Hirst CL; Pickersgill TP; Te Water Naude J; Wardle M; Ben-Shlomo Y; Robertson NP
    J Neurol Neurosurg Psychiatry; 2013 Feb; 84(2):141-7. PubMed ID: 23154123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cervical cord area is associated with infratentorial grey and white matter volume predominantly in relapsing-remitting multiple sclerosis: A study using semi-automated cord volumetry and voxel-based morphometry.
    Bellenberg B; Schneider R; Weiler F; Suchan B; Haghikia A; Hoffjan S; Gold R; Köster O; Lukas C
    Mult Scler Relat Disord; 2015 May; 4(3):264-72. PubMed ID: 26008944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multi-parametric structural magnetic resonance imaging in relation to cognitive dysfunction in long-standing multiple sclerosis.
    Daams M; Steenwijk MD; Schoonheim MM; Wattjes MP; Balk LJ; Tewarie PK; Killestein J; Uitdehaag BM; Geurts JJ; Barkhof F
    Mult Scler; 2016 Apr; 22(5):608-19. PubMed ID: 26209593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploring in vivo multiple sclerosis brain microstructural damage through T1w/T2w ratio: a multicentre study.
    Margoni M; Pagani E; Meani A; Storelli L; Mesaros S; Drulovic J; Barkhof F; Vrenken H; Strijbis E; Gallo A; Bisecco A; Pareto D; Sastre-Garriga J; Ciccarelli O; Yiannakas M; Palace J; Preziosa P; Rocca MA; Filippi M;
    J Neurol Neurosurg Psychiatry; 2022 Jul; 93(7):741-752. PubMed ID: 35580993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determinants of quality of life in pediatric- and adult-onset multiple sclerosis.
    McKay KA; Ernstsson O; Manouchehrinia A; Olsson T; Hillert J
    Neurology; 2020 Mar; 94(9):e932-e941. PubMed ID: 31732567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cortical lesion load associates with progression of disability in multiple sclerosis.
    Calabrese M; Poretto V; Favaretto A; Alessio S; Bernardi V; Romualdi C; Rinaldi F; Perini P; Gallo P
    Brain; 2012 Oct; 135(Pt 10):2952-61. PubMed ID: 23065788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cortical grey matter sodium accumulation is associated with disability and secondary progressive disease course in relapse-onset multiple sclerosis.
    Brownlee WJ; Solanky B; Prados F; Yiannakas M; Da Mota P; Riemer F; Cardoso MJ; Ourselin S; Golay X; Gandini Wheeler-Kingshott C; Ciccarelli O
    J Neurol Neurosurg Psychiatry; 2019 Jul; 90(7):755-760. PubMed ID: 30948625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain volume loss in multiple sclerosis is independent of disease activity and might be prevented by early disease-modifying therapy.
    Slezáková D; Kadlic P; Jezberová M; Boleková V; Valkovič P; Minar M
    Neurol Neurochir Pol; 2023; 57(3):282-288. PubMed ID: 37144903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinical impact of cerebellar grey matter pathology in multiple sclerosis.
    Damasceno A; Damasceno BP; Cendes F
    PLoS One; 2014; 9(5):e96193. PubMed ID: 24789257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of brain magnetic resonance imaging lesions in multiple sclerosis by race with reference to disability progression.
    Nakamura Y; Gaetano L; Matsushita T; Anna A; Sprenger T; Radue EW; Wuerfel J; Bauer L; Amann M; Shinoda K; Isobe N; Yamasaki R; Saida T; Kappos L; Kira JI
    J Neuroinflammation; 2018 Sep; 15(1):255. PubMed ID: 30185189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relevance of early cervical cord volume loss in the disease evolution of clinically isolated syndrome and early multiple sclerosis: a 2-year follow-up study.
    Hagström IT; Schneider R; Bellenberg B; Salmen A; Weiler F; Köster O; Gold R; Lukas C
    J Neurol; 2017 Jul; 264(7):1402-1412. PubMed ID: 28600596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No regional gray matter atrophy differences between pediatric- and adult-onset relapsing-remitting multiple sclerosis.
    Donohue K; Cox JL; Dwyer MG; Aliotta R; Corwin M; Weinstock-Guttman B; Ann Yeh E; Zivadinov R
    J Neuroimaging; 2014; 24(1):63-7. PubMed ID: 23317029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. White Matter Tract Injury is Associated with Deep Gray Matter Iron Deposition in Multiple Sclerosis.
    Bergsland N; Tavazzi E; Laganà MM; Baglio F; Cecconi P; Viotti S; Zivadinov R; Baselli G; Rovaris M
    J Neuroimaging; 2017 Jan; 27(1):107-113. PubMed ID: 27239049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased cortical curvature reflects white matter atrophy in individual patients with early multiple sclerosis.
    Deppe M; Marinell J; Krämer J; Duning T; Ruck T; Simon OJ; Zipp F; Wiendl H; Meuth SG
    Neuroimage Clin; 2014; 6():475-87. PubMed ID: 25610761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gray matter atrophy in multiple sclerosis despite clinical and lesion stability during natalizumab treatment.
    Koskimäki F; Bernard J; Yong J; Arndt N; Carroll T; Lee SK; Reder AT; Javed A
    PLoS One; 2018; 13(12):e0209326. PubMed ID: 30576361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Label-fusion-segmentation and deformation-based shape analysis of deep gray matter in multiple sclerosis: the impact of thalamic subnuclei on disability.
    Magon S; Chakravarty MM; Amann M; Weier K; Naegelin Y; Andelova M; Radue EW; Stippich C; Lerch JP; Kappos L; Sprenger T
    Hum Brain Mapp; 2014 Aug; 35(8):4193-203. PubMed ID: 24510715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoimmune comorbidities in multiple sclerosis: what is the influence on brain volumes? A case-control MRI study.
    Lorefice L; Fenu G; Pitzalis R; Scalas G; Frau J; Coghe G; Musu L; Sechi V; Barracciu MA; Marrosu MG; Cocco E
    J Neurol; 2018 May; 265(5):1096-1101. PubMed ID: 29508133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Corpus callosum index correlates with brain volumetry and disability in multiple sclerosis patients.
    Sugijono SE; Mulyadi R; Firdausia S; Prihartono J; Estiasari R
    Neurosciences (Riyadh); 2020 Jul; 25(3):193-199. PubMed ID: 32683399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The association of cognitive impairment with gray matter atrophy and cortical lesion load in clinically isolated syndrome.
    Diker S; Has AC; Kurne A; Göçmen R; Oğuz KK; Karabudak R
    Mult Scler Relat Disord; 2016 Nov; 10():14-21. PubMed ID: 27919482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.